##  [ANVISA Updates COVID Vaccine and Low-Risk Medicines Classification](/index%2ephp/mandate/anvisa-updates-covid-vaccine-and-low-risk-medicines-classification) 

March 25, 2026

ANVISA introduced updates affecting COVID-19 vaccine regulatory handling and revised the classification criteria for low-risk medicines. These changes aim to streamline regulatory oversight, optimize risk-based categorization, and improve efficiency in the evaluation and monitoring of lower-risk pharmaceutical products.



[Consult Now](/webform/consult%0A?url=https://preprod.freyrsolutions.com/index%2ephp/markdownify/node/12988)



Source

[https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2026/anvisa-atualiza-v…](https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2026/anvisa-atualiza-vacina-da-covid-e-lista-de-medicamentos-de-baixo-risco)

 

 

Select Mandate HA

[ANVISA](/index%2ephp/mandate-by-ha/anvisa)

 

Select Mandate Function

[Country Regulatory Affairs](/index%2ephp/mandate-by-function/country-regulatory-affairs)